Lung cancer: Pre-analytical phase challenges and biomarker testing
What are the common pre-analytical phase challenges in lung cancer, and how can we overcome them? Why is it important to identify genetic alterations? You are watching part 2 of a 3-part video podcast...
25 Jan 202427min
Treatment optimization in mCRC: third-line and beyond
Treatment of advanced colorectal cancer should be considered a continuum of care and patients should be offered as many life prolonging therapies as possible. Do you know how to sequence later line t...
10 Jan 202431min
Precision oncology: An overview of tumour agnostic therapies
What are tumour agnostic cancer treatments and which biomarkers do they target? Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston, Texas, United States) and Dr Tracy L S...
7 Des 202322min
Prostate Cancer: Pre-Analytical Phase Challenges and Biomarker Testing
What are the common pre-analytical phase challenges in prostate cancer, and how can we overcome them? Why is it important to identify genetic alterations? You are listening to part 1 of a 3-part video...
6 Des 202329min
Severe PHH. Part 2 - Learnings from clinical practice
In this podcast, Prof. Andra H. James (Professor Emeritus of Obstetrics and Gynecology, Division Maternal Fetal Medicine, Duke University Hospital, Durham, North Carolina, US) and Dr Maria Elisa Mancu...
6 Des 202323min
Managing thrombosis: Part 2 - Cancer and thrombosis
In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Dr Lars Asmis (Haematologist, University of Zurich, Switzerland) discuss the association between thr...
6 Des 202327min
Advanced HCC: 2nd line treatment and the right time to switch
Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at UZ Leuven, Belgium, discuss the new era in treating pati...
6 Des 202329min
Breast cancer: Oral SERDs in ER+ BC. Part 3 - Rare cases & treatment challenges
In this final episode, the experts discuss two patient case studies with oral SERDs (oral selective estrogen receptor degraders) and a novel therapy for ER+/HER2- advanced or metastatic breast cancer....
6 Des 202326min
